The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
Ohta S, Okamoto M, Fujimoto K, Sakamoto N, Takahashi K, Yamamoto H, Kushima H, Ishii H, Akasaka K, Ono J, Kamei A, Azuma Y, Matsumoto H, Yamaguchi Y, Aihara M, Johkoh T, Kawaguchi A, Ichiki M, Sagara H, Kadota JI, Hanaoka M, Hayashi SI, Kohno S, Hoshino T, Izuhara K; Consortium for Development of Diagnostics for Pulmonary Fibrosis Patients (CoDD-PF).
Ohta S, et al. Among authors: izuhara k.
PLoS One. 2017 Mar 29;12(3):e0174547. doi: 10.1371/journal.pone.0174547. eCollection 2017.
PLoS One. 2017.
PMID: 28355256
Free PMC article.